In our study, tumor tissues with high CXCR2P1 expression exhibited significantly higher proportions of activated CD4+ T cells and TFH cells compared to low CXCR2P1 expression tumor, suggesting that the tumor tissues with high CXCR2P1 expression may have higher immunogenicity. This evidence concerns the gene CD4 and neoplasm.